{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:14:55Z","timestamp":1781752495594,"version":"3.54.5"},"reference-count":0,"publisher":"BMJ","issue":"jan25 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2010,1,25]]},"DOI":"10.1136\/bmj.c477","type":"journal-article","created":{"date-parts":[[2010,1,25]],"date-time":"2010-01-25T12:43:19Z","timestamp":1264423399000},"page":"c477-c477","source":"Crossref","is-referenced-by-count":16,"title":["Withdrawal of sibutramine leaves European doctors with just one obesity drug"],"prefix":"10.1136","volume":"340","author":[{"given":"A.","family":"Sayburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2010,1,25]]},"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.c477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T21:16:56Z","timestamp":1601068616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.c477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,25]]},"references-count":0,"journal-issue":{"issue":"jan25 2","published-online":{"date-parts":[[2010,1,25]]},"published-print":{"date-parts":[[2010,1,25]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.c477","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,25]]}}}